Access the full text.
Sign up today, get DeepDyve free for 14 days.
Contrast media in breast imag
Se Jung, S. Heo, Jin Kim, Y. Jeong, S. Shin, Min-Gyu Soung, Heong Kim, H. Kang (2012)
Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: Diffusion‐weighted 3 tesla MR imagingJournal of Magnetic Resonance Imaging, 35
A. Idema, A. Hoffmann, H. Boogaarts, E. Troost, P. Wesseling, A. Heerschap, W. Graaf, J. Grotenhuis, W. Oyen (2012)
3′-Deoxy-3′-18F-Fluorothymidine PET–Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma PatientsThe Journal of Nuclear Medicine, 53
S. Punwani, S. Taylor, Z. Saad, A. Bainbridge, A. Groves, S. Daw, A. Shankar, S. Halligan, P. Humphries (2013)
Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI?European Journal of Nuclear Medicine and Molecular Imaging, 40
L. Curvo-Semedo, D. Lambregts, M. Maas, T. Thywissen, Rana Mehsen, G. Lammering, G. Beets, F. Caseiro-Alves, R. Beets-Tan (2011)
Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted MR imaging.Radiology, 260 3
M. Pickles, D. Manton, M. Lowry, L. Turnbull (2009)
Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy.European journal of radiology, 71 3
C. Hoekstra, S. Stroobants, E. Smit, J. Vansteenkiste, H. Tinteren, P. Postmus, R. Golding, B. Biesma, F. Schramel, N. Zandwijk, A. Lammertsma, O. Hoekstra (2005)
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 33
P. Tofts, A. Kermode (1991)
Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental conceptsMagnetic Resonance in Medicine, 17
V. Harry (2010)
Novel imaging techniques as response biomarkers in cervical cancer.Gynecologic oncology, 116 2
E. Eisenhauer, P. Therasse, J. Bogaerts, L. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, Lawrence Rubinstein, L. Shankar, L. Dodd, Robert Kaplan, D. Lacombe, J. Verweij (2009)
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).European journal of cancer, 45 2
M. Intven, M. Intven, O. Reerink, O. Reerink, M. Philippens, M. Philippens (2013)
Diffusion-weighted MRI in locally advanced rectal cancerStrahlentherapie und Onkologie, 189
S Yoshida (2012)
Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancerInt J Radiat Oncol Biol Phys., 83
(2013)
Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in monitoring the response of breast cancer to neoadjuvant chemotherapy: a metaanalysis
E. Coche (2013)
Recist and beyond.JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie, 96 3
T. Julius, S. Kemp, P. Kneeshaw, A. Chaturvedi, P. Drew, L. Turnbull (2005)
MRI and conservative treatment of locally advanced breast cancer.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 31 10
N. Mayr, W. Yuh, J. Arnholt, J. Ehrhardt, J. Sorosky, V. Magnotta, K. Berbaum, W. Zhen, A. Paulino, L. Oberley, A. Sood, J. Buatti (2000)
Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancerJournal of Magnetic Resonance Imaging, 12
S. Hahn, E. Ko, B. Han, J. Shin, E. Ko (2014)
Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.European journal of radiology, 83 2
Chenpeng Zhang, J. Tong, Xiaoguang Sun, Jianju Liu, Yuting Wang, Gang Huang (2012)
18F‐FDG‐PET evaluation of treatment response to neo‐adjuvant therapy in patients with locally advanced rectal cancer: A meta‐analysisInternational Journal of Cancer, 131
K Surlan-Popovic (2010)
Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapyAJNR Am J Neuroradiol., 31
F. Agnello, G. Salvaggio, G. Cabibbo, M. Maida, R. Lagalla, M. Midiri, G. Brancatelli (2013)
Imaging appearance of treated hepatocellular carcinoma.World journal of hepatology, 5 8
P. Box (2011)
Rectal cancer:assessment of complete response to preoperative combined radiation therapy with chemotherapy—conventional MR volumetry versus diffusion-weighted MR imagingInternational Journal of Medical Radiology
P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan, L. Rubinstein, J. Verweij, M. Glabbeke, A. Oosterom, M. Christian, S. Gwyther (2000)
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.Journal of the National Cancer Institute, 92 3
Jin He, A. Page, M. Weiss, elliot fishman, J. Herman, T. Pawlik (2014)
Management of borderline and locally advanced pancreatic cancer: where do we stand?World journal of gastroenterology, 20 9
F. Grossi, O. Belvedere, G. Fasola, T. Ceschia, S. Meduri, A. Sibau, C. Sacco, M. Bazzocchi, G. Talmassons, A. Morelli, F. Barbone, A. Sobrero (2004)
Tumor measurements on computed tomographic images of non-small cell lung cancer were similar among cancer professionals from different specialties.Journal of clinical epidemiology, 57 8
Hyun Jang, Byung Kim, H. Kim, Jung Kim, H. Song, J. Kim, J. Park, Shinkyo Yoon, J. Woo, D. Zang (2014)
Comparison of RECIST 1.0 and RECIST 1.1 on Computed Tomography in Patients with Metastatic Colorectal CancerOncology, 86
M. Lambrecht, V. Vandecaveye, F. Keyzer, S. Roels, F. Penninckx, E. Cutsem, Claus Filip, K. Haustermans (2012)
Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.International journal of radiation oncology, biology, physics, 82 2
(2007)
Repeat 18 F - FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non - small cell
Sofie Cauter, J. Veraart, Jan Sijbers, R. Peeters, U. Himmelreich, F. Keyzer, S. Gool, F. Calenbergh, S. Vleeschouwer, W. Hecke, S. Sunaert (2012)
Gliomas: diffusion kurtosis MR imaging in grading.Radiology, 263 2
M. Bellomi, G. Petralia, A. Sonzogni, M. Zampino, A. Rocca (2007)
CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience.Radiology, 244 2
Alexander Vries, Jürgen Griebel, Christian Kremser, W. Judmaier, T. Gneiting, P. Debbage, Thomas Kremser, Karl Pfeiffer, Wolfgang Buchberger, Peter Lukas (2000)
Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy.Radiology, 217 2
L. Capussotti, A. Muratore (2006)
Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary (Br J Surg) 2006; 93; 872–878British Journal of Surgery, 93
R. Wong, D. Cunningham, Y. Barbáchano, C. Saffery, J. Valle, T. Hickish, S. Mudan, G. Brown, Adeel Khan, A. Wotherspoon, A. Strimpakos, Janet Thomas, S. Compton, Y. Chua, I. Chau (2011)
A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection.Annals of oncology : official journal of the European Society for Medical Oncology, 22 9
K. Spaepen, S. Stroobants, P. Dupont, S. Steenweghen, J. Thomas, P. Vandenberghe, L. Vanuytsel, G. Bormans, J. Balzarini, C. Wolf-Peeters, L. Mortelmans, G. Verhoef (2001)
Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 2
D. Rischin, R. Hicks, R. Fisher, D. Binns, J. Corry, S. Porceddu, L. Peters (2006)
Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 13
Sonia Li, N. Taylor, A. Makris, M. Ah-See, M. Beresford, J. Stirling, J. d’Arcy, D. Collins, A. Padhani (2010)
Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.Radiology, 257 3
(2004)
pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia.
I. Song, Seong Kim, Seon-Ho Lee, Jungku Choi, Min Kim, H. Rhim (2012)
Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging.The British journal of radiology, 85 1013
Q. Ng, V. Goh, J. Milner, A. Padhani, M. Saunders, P. Hoskin (2007)
Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography.International journal of radiation oncology, biology, physics, 67 2
K. Holzapfel, M. Bruegel, M. Eiber, C. Ganter, T. Schuster, P. Heinrich, E. Rummeny, J. Gaa (2010)
Characterization of small (≤10 mm) focal liver lesions: value of respiratory-triggered echo-planar diffusion-weighted MR imaging.European journal of radiology, 76 1
F. Makowiec, P. Baier, B. Kulemann, G. Marjanovic, P. Bronsert, K. Zirlik, M. Henke, U. Hopt, J. Hoeppner (2013)
Improved Long-Term Survival After Esophagectomy for Esophageal Cancer: Influence of Epidemiologic Shift and Neoadjuvant TherapyJournal of Gastrointestinal Surgery, 17
A. Devries, J. Griebel, C. Kremser, W. Judmaier, T. Gneiting, A. Kreczy, D. Ofner, K. Pfeiffer, G. Brix, P. Lukas (2001)
Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma.Cancer research, 61 6
A. Devries, C. Kremser, P. Hein, J. Griebel, Alfons Krezcy, D. Ofner, K. Pfeiffer, P. Lukas, W. Judmaier (2003)
Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma.International journal of radiation oncology, biology, physics, 56 4
U. Sharma, K. Danishad, V. Seenu, N. Jagannathan (2009)
Longitudinal study of the assessment by MRI and diffusion‐weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapyNMR in Biomedicine, 22
J. Llovet, A. Bisceglie, J. Bruix, B. Kramer, R. Lencioni, A. Zhu, M. Sherman, M. Schwartz, M. Lotze, J. Talwalkar, G. Gores (2008)
Design and endpoints of clinical trials in hepatocellular carcinoma.Journal of the National Cancer Institute, 100 10
M. Zahra, K. Hollingsworth, E. Sala, D. Lomas, L. Tan (2007)
Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy.The Lancet. Oncology, 8 1
R. Hermans, M. Meijerink, W. Bogaert, A. Rijnders, C. Weltens, P. Lambin (2003)
Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy.International journal of radiation oncology, biology, physics, 57 5
T. Hauser, M. Essig, A. Jensen, F. Laun, M. Münter, Klaus Maier-Hein, B. Stieltjes (2014)
Prediction of treatment response in head and neck carcinomas using IVIM-DWI: Evaluation of lymph node metastasis.European journal of radiology, 83 5
P. Dirix, V. Vandecaveye, F. Keyzer, S. Stroobants, R. Hermans, S. Nuyts (2009)
Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with 18F-FDG PET, 18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRIJournal of Nuclear Medicine, 50
H. Ha, A. Kim, C. Yu, S. Park, H. Ha (2013)
Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapyEuropean Radiology, 23
S. Chawla, S. Kim, L. Dougherty, Sumei Wang, L. Loevner, H. Quon, Harish Poptani (2013)
Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck.AJR. American journal of roentgenology, 200 1
V. Trillet‐Lenoir, G. Freyer, P. Kaemmerlen, A. Fond, O. Pellet, C. Lombard-Bohas, J Gaudin, G. Lledo, R. Mackiewicz, M Gouttebel, H. Moindrot, J Boyer, L. Chassignol, N. Stremsdoerfer, F. Desseigne, J Moreau, F. Hedelius, A. Moraillon, F. Chapuis, J Bleuse, Y. Barbier, M Heilmann, P Valette (2002)
Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteria.The British journal of radiology, 75 899
M. Juweid, G. Wiseman, J. Vose, J. Ritchie, Y. Menda, J. Wooldridge, F. Mottaghy, E. Rohren, N. Blumstein, A. Stolpen, B. Link, S. Reske, M. Graham, B. Cheson (2005)
Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 21
L. Gianni, W. Eiermann, V. Semiglazov, A. Lluch, S. Tjulandin, M. Zambetti, A. Moliterni, F. Vázquez, M. Byakhov, M. Lichinitser, M. Climent, E. Ciruelos, B. Ojeda, M. Mansutti, A. Bozhok, D. Magazzù, D. Heinzmann, J. Steinseifer, P. Valagussa, J. Baselga (2014)
Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort.The Lancet. Oncology, 15 6
F. Dias (2013)
Assessment of Treatment Response after Chemoradiation of Head and Neck CancerCurrent Oncology Reports, 15
F. Mghanga, X. Lan, K. Bakari, Chongjiao Li, Yongxue Zhang (2013)
Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in monitoring the response of breast cancer to neoadjuvant chemotherapy: a meta-analysis.Clinical breast cancer, 13 4
Chieh Lin, E. Itti, A. Luciani, B. Zegai, Shih-jui Lin, F. Kuhnowski, F. Pigneur, I. Gaillard, G. Paone, M. Meignan, C. Haioun, A. Rahmouni (2011)
Whole-Body Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Treatment Response Assessment in Patients With Diffuse Large B-Cell Lymphoma: Pilot StudyInvestigative Radiology, 46
Yanming Yu, Q. Jiang, Yanwei Miao, Jun Li, S. Bao, Haoyu Wang, Chun-xue Wu, Xiaoying Wang, Jiong Zhu, Yi Zhong, E. Haacke, Jiani Hu (2010)
Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer.Radiology, 257 1
M. Maas, R. Beets-Tan, D. Lambregts, G. Lammering, P. Nelemans, S. Engelen, R. Dam, R. Jansen, M. Sosef, J. Leijtens, K. Hulsewé, J. Buijsen, G. Beets (2011)
Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 35
M. Heldahl, T. Bathen, J. Rydland, K. Kvistad, S. Lundgren, I. Gribbestad, P. Goa (2010)
Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: Overall survival predicted from combined time course and volume analysisActa Radiologica, 51
T. Barwick, Badreddine Bencherif, J. Mountz, N. Avril (2009)
Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluationNuclear Medicine Communications, 30
(2010)
Characterization of small (B=10 mm) focal liver lesions: value of respiratory-triggered echo-planar diffusion-weighted MR imaging
Francesco Mungai, F. Pasquinelli, L. Mazzoni, G. Virgili, A. Ragozzino, E. Quaia, G. Morana, A. Giovagnoni, L. Grazioli, S. Colagrande (2014)
Diffusion-weighted magnetic resonance imaging in the prediction and assessment of chemotherapy outcome in liver metastasesLa radiologia medica, 119
Jing Yu, Weidong Li, Zhang Zhang, T. Yu, Dong Li (2014)
Prediction of Early Response to Chemotherapy in Lung Cancer by Using Diffusion-Weighted MR ImagingThe Scientific World Journal, 2014
B. Gagel, P. Reinartz, E. Dimartino, M. Zimny, M. Pinkawa, P. Maneschi, S. Stanzel, K. Hamacher, H. Coenen, M. Westhofen, U. Büll, M. Eble (2004)
pO2 Polarography Versus Positron Emission Tomography ([18F] Fluoromisonidazole, [18F]-2-Fluoro-2’-Deoxyglucose)Strahlentherapie und Onkologie, 180
S. Lastoria, M. Piccirillo, C. Caracó, G. Nasti, L. Aloj, C. Arrichiello, E. Castelguidone, F. Tatangelo, A. Ottaiano, R. Iaffaioli, F. Izzo, G. Romano, P. Giordano, S. Signoriello, C. Gallo, F. Perrone (2013)
Early PET/CT Scan Is More Effective Than RECIST in Predicting Outcome of Patients with Liver Metastases from Colorectal Cancer Treated with Preoperative Chemotherapy Plus BevacizumabThe Journal of Nuclear Medicine, 54
A. Forner, C. Ayuso, M. Varela, J. Rimola, A. Hessheimer, C. Lope, M. Reig, L. Bianchi, J. Llovet, J. Bruix (2009)
Evaluation of tumor response after locoregional therapies in hepatocellular carcinomaCancer, 115
C. Eccles, E. Haider, M. Haider, S. Fung, G. Lockwood, L. Dawson (2009)
Change in diffusion weighted MRI during liver cancer radiotherapy: Preliminary observationsActa Oncologica, 48
A Forner (2009)
Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?Cancer., 115
(2012)
30-Deoxy-30-18F-fluorothymidine PET-derived proliferative volume predicts overall survival in high-grade glioma patients
R. Beets-Tan, D. Lambregts, M. Maas, S. Bipat, B. Barbaro, F. Caseiro-Alves, L. Curvo-Semedo, H. Fenlon, M. Gollub, S. Gourtsoyianni, S. Halligan, C. Hoeffel, S. Kim, A. Laghi, A. Maier, S. Rafaelsen, J. Stoker, S. Taylor, M. Torkzad, L. Blomqvist (2018)
Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meetingEuropean Radiology, 23
O. Humbert, A. Berriolo-Riedinger, A. Cochet, M. Gauthier, C. Charon-Barra, S. Guiu, I. Desmoulins, M. Toubeau, I. Dygai-Cochet, C. Coutant, P. Fumoleau, F. Brunotte (2014)
Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using 18F-FDG PET in luminal HER2-negative breast cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 41
S. Gambhir (2002)
Molecular imaging of cancer with positron emission tomographyNature Reviews Cancer, 2
G. Mentha, P. Majno, A. Andres, L. Rubbia-Brandt, P. Morel, Arnaud Roth (2006)
Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primaryBritish Journal of Surgery, 93
S. Kim, Jeong Lee, Sung Hong, G. Kim, Jae Lee, J. Han, B. Choi (2009)
Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy.Radiology, 253 1
B. Glimelius, J Oliveira (2008)
Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.Annals of oncology : official journal of the European Society for Medical Oncology, 19 Suppl 2
(2014)
value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusionweighted MRI, and dynamic contrast-enhanced MRI
JF Jansen (2010)
Non-gaussian analysis of diffusion-weighted MR imaging in head and neck squamous cell carcinoma: A feasibility studyAJNR Am J Neuroradiol., 31
D. Ippolito, L. Monguzzi, L. Guerra, Elena Deponti, G. Gardani, C. Messa, S. Sironi (2012)
Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CTAbdominal Imaging, 37
R. Vera, M. Dorronsoro, S. López-Ben, A. Viúdez, B. Queralt, Irene Hernández, M. Ortiz-Duran, C. Zazpe, J. Soriano, I. Amat, J. Cabezón, E. Díaz, A. Codina-Barreras, X. Hernández-Yagüe, A. Quera, J. Figueras (2014)
Retrospective analysis of pathological response in colorectal cancer liver metastases following treatment with bevacizumabClinical and Translational Oncology, 16
Hyun Kim, C. Kim, B. Park, S. Huh, Bohyun Kim (2013)
Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion‐weighted MR imagingJournal of Magnetic Resonance Imaging, 37
M. Marinovich, N. Houssami, P. Macaskill, F. Sardanelli, L. Irwig, E. Mamounas, G. Minckwitz, M. Brennan, S. Ciatto (2013)
Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy.Journal of the National Cancer Institute, 105 5
M. George, Andrzej Dzik-Jurasz, Anwar Padhani, Gina Brown, Diana Tait, Suzanne Eccles, R. Swift (2001)
Non‐invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancerBritish Journal of Surgery, 88
Yingshi Sun, Xiao-Peng Zhang, Lei Tang, J. Ji, J. Gu, Y. Cai, Xiaoyan Zhang (2010)
Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging.Radiology, 254 1
(2013)
Diffusion-weighted MRI in locally advanced rectal cancer : pathological response prediction after neo-adjuvant radiochemotherapy
M. Kaufmann, G. Hortobagyi, A. Goldhirsch, S. Scholl, A. Makris, P. Valagussa, J. Blohmer, W. Eiermann, R. Jackesz, W. Jonat, A. Lebeau, S. Loibl, W. Miller, Sigfried Seeber, V. Semiglazov, Roy Smith, R. Souchon, V. Stearns, M. Untch, G. Minckwitz (2006)
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 12
H. Vesselle, J. Grierson, M. Muzi, Jeffrey Pugsley, R. Schmidt, Peter Rabinowitz, L. Peterson, E. Vallières, D. Wood (2002)
In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 11
K. Lehtiö, O. Eskola, T. Viljanen, V. Oikonen, T. Grönroos, L. Sillanmäki, R. Grénman, H. Minn (2004)
Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer.International journal of radiation oncology, biology, physics, 59 4
Roar Johansen, L. Jensen, J. Rydland, P. Goa, K. Kvistad, T. Bathen, D. Axelson, S. Lundgren, I. Gribbestad (2009)
Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE‐MRIJournal of Magnetic Resonance Imaging, 29
S. Ben-Haim, P. Ell (2008)
18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response*Journal of Nuclear Medicine, 50
C. Kenis, F. Deckers, B. Foer, F. Mieghem, S. Laere, M. Pouillon (2012)
Diagnosis of liver metastases: can diffusion-weighted imaging (DWI) be used as a stand alone sequence?European journal of radiology, 81 5
J. Loncaster, B. Carrington, J. Sykes, Andrew Jones, S. Todd, R. Cooper, D. Buckley, S. Davidson, J. Logue, R. Hunter, C. West (2002)
Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix.International journal of radiation oncology, biology, physics, 54 3
M. Marinovich, F. Sardanelli, S. Ciatto, E. Mamounas, M. Brennan, P. Macaskill, L. Irwig, G. Minckwitz, N. Houssami (2012)
Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI.Breast, 21 5
W. Elmpt, M. Öllers, A. Dingemans, P. Lambin, D. Ruysscher (2012)
Response Assessment Using 18F-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non–Small Cell Lung CancerThe Journal of Nuclear Medicine, 53
R. Salgia, A. Singal (2014)
Hepatocellular carcinoma and other liver lesions.The Medical clinics of North America, 98 1
R. Hermans, P. Lambin, A. Goten, W. Bogaert, B. Verbist, C. Weltens, P. Delaere (1999)
Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 53 2
A. Habr-Gama, R. Perez, I. Proscurshim, F. Campos, W. Nadalin, D. Kiss, J. Gama-Rodrigues (2006)
Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapyJournal of Gastrointestinal Surgery, 10
P. Therasse, E. Eisenhauer, J. Verweij (2006)
RECIST revisited: a review of validation studies on tumour assessment.European journal of cancer, 42 8
M. Hatt, D. Groheux, A. Martineau, M. Espié, E. Hindié, S. Giacchetti, A. Roquancourt, D. Visvikis, C. Rest (2013)
Comparison Between 18F-FDG PET Image–Derived Indices for Early Prediction of Response to Neoadjuvant Chemotherapy in Breast CancerThe Journal of Nuclear Medicine, 54
G. Spinzi, S. Paggi (2008)
Sorafenib in advanced hepatocellular carcinoma.The New England journal of medicine, 359 23
R. Dresen, G. Beets, H. Rutten, S. Engelen, M. Lahaye, R. Vliegen, A. Bruïne, A. Kessels, G. Lammering, R. Beets-Tan (2009)
Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall?Radiology, 252 1
S. Yoshida, F. Koga, Shuichiro Kobayashi, C. Ishii, Hiroshi Tanaka, Hajime Tanaka, Y. Komai, K. Saito, H. Masuda, Y. Fujii, S. Kawakami, K. Kihara (2012)
Clinical Investigation : Genitourinary Cancer Role of Diffusion-Weighted Magnetic Resonance Imaging in Predicting Sensitivity to Chemoradiotherapy in Muscle-Invasive Bladder Cancer
D. Koh, E. Scurr, D. Collins, B. Kanber, A. Norman, M. Leach, J. Husband (2007)
Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients.AJR. American journal of roentgenology, 188 4
D. Lambregts, V. Vandecaveye, B. Barbaro, F. Bakers, M. Lambrecht, M. Maas, K. Haustermans, V. Valentini, G. Beets, R. Beets-Tan (2011)
Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter StudyAnnals of Surgical Oncology, 18
M. Janssen, M. Ollers, R. Riedl, J. Bogaard, J. Buijsen, R. Stiphout, H. Aerts, P. Lambin, G. Lammering (2010)
Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging.International journal of radiation oncology, biology, physics, 77 2
(2004)
pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-20deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia
H. Makino, H. Kato, T. Furui, K. Morishige, M. Kanematsu (2014)
Predictive value of diffusion‐weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancerJournal of Obstetrics and Gynaecology Research, 40
J. Guillem, J. Calle, T. Akhurst, S. Tickoo, L. Ruo, B. Minsky, M. Gollub, D. Klimstra, M. Mazumdar, P. Paty, H. Macapinlac, H. Yeung, L. Saltz, R. Finn, Y. Erdi, J. Humm, A. Cohen, S. Larson (2000)
Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomographyDiseases of the Colon & Rectum, 43
Haesun Choi, C. Charnsangavej, S. Faria, H. Macapinlac, M. Burgess, Shreyaskumar Patel, Lei Chen, D. Podoloff, R. Benjamin (2007)
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 13
T. Arizumi, K. Ueshima, Haruhiko Takeda, Y. Osaki, M. Takita, Tatsuo Inoue, S. Kitai, N. Yada, S. Hagiwara, Y. Minami, T. Sakurai, N. Nishida, M. Kudo (2014)
Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinomaJournal of Gastroenterology, 49
P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan, L. Rubinstein, J. Verweij, M. Glabbeke, Allan Oosterom, M. Christian, S. Gwyther (2000)
New guidelines to evaluate the response to treatment in solid tumorsBreast Cancer, 12
T. Seierstad, K. Røe, D. Olsen (2007)
Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal tumor model.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 85 2
Sonia Li, A. Makris, M. Beresford, N. Taylor, M. Ah-See, J. Stirling, J. d’Arcy, D. Collins, R. Kozarski, A. Padhani (2011)
Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.Radiology, 260 1
G. Engin, R. Sharifov, Z. Güral, Esra Sağam, S. Saglam, E. Balik, Oktar Asoğu, S. Yamaner, Mine Güllüoğu, Y. Kapran, S. Özel (2012)
Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer?Diagnostic and interventional radiology, 18 6
S. Eschmann, Godehard Friedel, Frank Paulsen, Matthias Reimold, T. Hehr, W. Budach, Helmut Dittmann, Heinz-Jakob Langen, Roland Bares (2007)
Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer.Lung cancer, 55 2
Jacobus Jansen, H. Stambuk, J. Koutcher, A. Shukla-Dave (2010)
Non-Gaussian Analysis of Diffusion-Weighted MR Imaging in Head and Neck Squamous Cell Carcinoma: A Feasibility StudyAmerican Journal of Neuroradiology, 31
L. Shankar, J. Hoffman, S. Bacharach, M. Graham, J. Karp, A. Lammertsma, S. Larson, D. Mankoff, B. Siegel, A. Abbeele, J. Yap, D. Sullivan (2006)
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 47 6
D. Sahani, S. Kalva, L. Hamberg, P. Hahn, C. Willett, S. Saini, P. Mueller, Ting-Yim Lee (2005)
Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations.Radiology, 234 3
L. Serrano, Brooke Morrell, Andrew Mai (2012)
Contrast media in breast imaging.Magnetic resonance imaging clinics of North America, 20 4
K. Surlan-Popovic, S. Bisdas, Z. Rumboldt, T. Koh, P. Strojan (2010)
Changes in Perfusion CT of Advanced Squamous Cell Carcinoma of the Head and Neck Treated during the Course of Concomitant ChemoradiotherapyAmerican Journal of Neuroradiology, 31
Neoadjuvant therapy has become part of standard treatment in several types of cancer. Therapeutic effects are often assessed with imaging. The main purpose of response assessment is to define resectability and determine surgical approach. Another controversial purpose of response assessment is selecting patients with complete tumor regression for non-operative strategies. Moreover, response prediction early during treatment can lead to alteration of the initial treatment plan. Another role for pre-treatment imaging lies in the assessment of individual tumor risk profile, to select which patients benefit most from neoadjuvant therapy. Finally, there is a new role for imaging in the guidance of treatment efficacy. This review discusses the different imaging modalities used in clinics to evaluate and predict treatment response in various tumor types. Established response methods such as RECIST and FDG-PET are discussed. Functional imaging methods such as diffusion-weighted MR imaging, perfusion imaging, and novel PET-imaging techniques are described.
Current Radiology Reports – Springer Journals
Published: Jul 18, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.